178 related articles for article (PubMed ID: 16649014)
1. [Recombinant activated factor VIIa for treatment of traumatic liver rupture].
Leidinger W; Meierhofer JN; Woelfel R
Anaesthesist; 2006 Aug; 55(8):868-72. PubMed ID: 16649014
[TBL] [Abstract][Full Text] [Related]
2. Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa.
Schuster R; Lee SJ; Rink D
Am Surg; 2003 Nov; 69(11):1017-8. PubMed ID: 14627269
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa as an adjunct in nonoperative management of solid organ injuries in children.
Vick LR; Islam S
J Pediatr Surg; 2008 Jan; 43(1):195-8; discussion 198-9. PubMed ID: 18206482
[TBL] [Abstract][Full Text] [Related]
4. Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.
Kluger Y; Riou B; Rossaint R; Rizoli SB; Boffard KD; Choong PI; Warren B; Tillinger M
Crit Care; 2007; 11(4):R85. PubMed ID: 17686152
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs.
Grottke O; Braunschweig T; Zimmermann L; Kopp R; Lauritzen B; Coburn M; Tolba R; Rossaint R
Br J Anaesth; 2010 Dec; 105(6):789-97. PubMed ID: 20926476
[TBL] [Abstract][Full Text] [Related]
6. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A; Vaghela M; Lawton G; Sigston P
Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
[TBL] [Abstract][Full Text] [Related]
7. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
Schreiber MA; Holcomb JB; Hedner U; Brundage SI; Macaitis JM; Hoots K
J Trauma; 2002 Aug; 53(2):252-7; discussion 257-9. PubMed ID: 12169930
[TBL] [Abstract][Full Text] [Related]
8. [Intraoperative use of recombinant activated factor VII in traumatic unpenetrating liver injury--case report].
Popović D
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():249-52. PubMed ID: 19562878
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Factor VIIa in blunt pelvic trauma.
Hurst T; Blanckley S; Forrest M
Anaesthesia; 2005 Dec; 60(12):1244-5; author reply 1245. PubMed ID: 16288629
[No Abstract] [Full Text] [Related]
10. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma.
Geeraedts LM; Kamphuisen PW; Kaasjager HA; Verwiel JM; van Vugt AB; Frölke JP
Injury; 2005 Apr; 36(4):495-500. PubMed ID: 15755430
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia.
Spronk HM; Braunschweig T; Rossaint R; Wüst DC; van Oerle R; Lauritzen B; Tolba R; Grottke O
PLoS One; 2015; 10(6):e0113979. PubMed ID: 26098426
[TBL] [Abstract][Full Text] [Related]
12. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register.
Isbister J; Phillips L; Dunkley S; Jankelowitz G; McNeil J; Cameron P
Intern Med J; 2008 Mar; 38(3):156-65. PubMed ID: 17916172
[TBL] [Abstract][Full Text] [Related]
13. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
Martinowitz U; Holcomb JB; Pusateri AE; Stein M; Onaca N; Freidman M; Macaitis JM; Castel D; Hedner U; Hess JR
J Trauma; 2001 Apr; 50(4):721-9. PubMed ID: 11303171
[TBL] [Abstract][Full Text] [Related]
14. The use of recombinant activated factor VII in trauma-associated hemorrhage with crush injury.
Christians K; Brasel K; Garlitz J; Abu-Hajir M; Gottschall J
J Trauma; 2005 Sep; 59(3):742-6. PubMed ID: 16361923
[No Abstract] [Full Text] [Related]
15. Use of recombinant factor VIIA for control of combat-related haemorrhage.
Woodruff SI; Dougherty AL; Dye JL; Mohrle CR; Galarneau MR
Emerg Med J; 2010 Feb; 27(2):121-4. PubMed ID: 20156864
[TBL] [Abstract][Full Text] [Related]
16. Successful use of activated recombinant factor VII in traumatic liver injuries in children.
Kulkarni R; Daneshmand A; Guertin S; Fath J; Atwal M; Melvin J; LaFrance S
J Trauma; 2004 Jun; 56(6):1348-52. PubMed ID: 15211149
[No Abstract] [Full Text] [Related]
17. Local and systemic hemostatics as an adjunct to control bleeding in trauma.
Georgiou C; Neofytou K; Demetriades D
Am Surg; 2013 Feb; 79(2):180-7. PubMed ID: 23336658
[TBL] [Abstract][Full Text] [Related]
18. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
19. Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
Končar IB; Davidović LB; Savić N; Sinđelić RB; Ilić N; Dragas M; Markovic M; Kostic D
J Vasc Surg; 2011 Apr; 53(4):1032-7. PubMed ID: 21215579
[TBL] [Abstract][Full Text] [Related]
20. Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.
Tatoulis J; Theodore S; Meswani M; Wynne R; Hon-Yap C; Powar N
Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):459-62. PubMed ID: 19542087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
